|

SCG142 TCR-T cells Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • The Affiliated Hospital of Qingdao University1

Indications

  • Human Papillomavirus Associated Carcinomas1
  • HPV-Related Malignancy1
  • Vulva Cancer1
  • Head and Neck Cancers1
  • Penile Cancer1

Other1 trial

SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.